Refine by
Infectious Disease Emergency Manufacturer
8 companies found
Manufacturerbased inAbbiategrasso, ITALY
Since 1987, Clonit has been focused in developing, manufacturing and distributing of innovative and reliable in Vitro Diagnostic Equipment and Reagents for Molecular Diagnostics. A deep expertise in Molecular Biology mixed to our strong culture of ...
Manufacturerbased inLyon, FRANCE
Fab’entech is a French biotech created in 2009 and specialised in the development and production of polyclonal antibodies intended for the treatment of emerging infectious diseases and biodefense solutions. Lifestyles, the globalisation of ...
Fab’entech’s solutions are based on the production of polyclonal antibodies. These antibodies replace those that the patient has not had time to produce naturally. They recognise then neutralise the virus or toxin in only a few minutes, ...
Manufacturerbased inBurlingame, CALIFORNIA (USA)
Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. This test has not yet been ...
Manufacturerbased inNew York, NEW YORK (USA)
SIGA Technologies, Inc. is a public, commercial-stage pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear ...
Manufacturerbased inResearch Triangle Park, NORTH CAROLINA (USA)
Galaxy Diagnostics was launched in 2009 to commercialize a more sensitive test method for Bartonella species infection, called Bartonella ePCR. The underlying technology, developed by Galaxy cofounders, Drs. Ed Breitschwerdt and Ricardo Maggi at NC ...
Manufacturerbased inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro Vaccines has developed a VesiculoVax™-vectored vaccine to protect against Lassa hemorrhagic ...
Manufacturerbased inMarcy l`Etoile, FRANCE
Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. A family-owned company, bioMérieux has grown to become a world leader in the ...
Manufacturerbased inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
CYNK-001 is the only cryopreserved, allogeneic, off-the-shelf, natural killer (NK) cell therapy being developed from placental hematopoietic stem cells as a potential treatment option for various hematologic cancers, solid tumors, and infectious ...